Syngen Biotech Co.,Ltd. (TPEX:8279)
Taiwan
· Delayed Price · Currency is TWD 129.50
+2.00 (1.57%)
Feb 21, 2025, 1:30 PM CST
Syngen Biotech Ratios and Metrics
Market cap in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Feb '25 Feb 20, 2025 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Market Capitalization | 3,510 | 4,119 | 4,390 | 3,062 | 2,927 | 3,184 | Upgrade
|
| Market Cap Growth | -20.18% | -6.17% | 43.36% | 4.63% | -8.09% | 43.44% | Upgrade
|
| Enterprise Value | 3,698 | 4,390 | 4,817 | 3,106 | 2,887 | 3,114 | Upgrade
|
| Last Close Price | 129.50 | 147.25 | 152.43 | 103.01 | 94.65 | 100.24 | Upgrade
|
| PE Ratio | 14.70 | 14.99 | 13.67 | 12.88 | 13.58 | 16.87 | Upgrade
|
| Forward PE | - | 12.75 | 14.48 | 13.20 | 13.20 | 16.12 | Upgrade
|
| PS Ratio | 1.75 | 2.24 | 2.27 | 2.08 | 2.23 | 2.45 | Upgrade
|
| PB Ratio | 1.61 | 1.93 | 2.20 | 1.73 | 1.80 | 2.14 | Upgrade
|
| P/TBV Ratio | 1.66 | 1.95 | 2.23 | 1.75 | 1.83 | 2.18 | Upgrade
|
| P/FCF Ratio | 13.80 | 12.74 | - | 11.14 | - | 21.39 | Upgrade
|
| P/OCF Ratio | 10.51 | 9.92 | 15.82 | 9.10 | 13.29 | 12.48 | Upgrade
|
| EV/Sales Ratio | 1.85 | 2.39 | 2.49 | 2.11 | 2.20 | 2.40 | Upgrade
|
| EV/EBITDA Ratio | 8.98 | 11.37 | 11.13 | 8.93 | 8.97 | 10.59 | Upgrade
|
| EV/EBIT Ratio | 12.23 | 14.50 | 13.29 | 11.03 | 11.14 | 12.82 | Upgrade
|
| EV/FCF Ratio | 14.54 | 13.58 | - | 11.30 | - | 20.92 | Upgrade
|
| Debt / Equity Ratio | 0.19 | 0.25 | 0.30 | 0.13 | 0.15 | 0.10 | Upgrade
|
| Debt / EBITDA Ratio | 1.01 | 1.34 | 1.34 | 0.65 | 0.75 | 0.50 | Upgrade
|
| Debt / FCF Ratio | 1.64 | 1.67 | - | 0.86 | - | 1.03 | Upgrade
|
| Asset Turnover | 0.66 | 0.59 | 0.70 | 0.65 | 0.65 | 0.80 | Upgrade
|
| Inventory Turnover | 4.04 | 3.32 | 3.76 | 3.42 | 3.36 | 3.86 | Upgrade
|
| Quick Ratio | 1.50 | 1.29 | 1.00 | 1.68 | 2.31 | 2.80 | Upgrade
|
| Current Ratio | 2.21 | 1.94 | 1.55 | 2.43 | 3.26 | 3.67 | Upgrade
|
| Return on Equity (ROE) | 11.22% | 13.33% | 17.07% | 14.00% | 13.83% | 15.97% | Upgrade
|
| Return on Assets (ROA) | 6.30% | 6.13% | 8.26% | 7.75% | 7.99% | 9.40% | Upgrade
|
| Return on Capital (ROIC) | 7.24% | 7.19% | 9.85% | 9.06% | 9.20% | 11.31% | Upgrade
|
| Return on Capital Employed (ROCE) | 12.06% | 12.01% | 15.41% | 14.10% | 14.29% | 14.85% | Upgrade
|
| Earnings Yield | 6.80% | 6.67% | 7.32% | 7.76% | 7.36% | 5.93% | Upgrade
|
| FCF Yield | 7.24% | 7.85% | -6.99% | 8.97% | -1.80% | 4.68% | Upgrade
|
| Dividend Yield | 3.86% | 3.40% | 3.28% | 3.88% | 3.70% | 2.99% | Upgrade
|
| Payout Ratio | 56.75% | 49.31% | 33.75% | 39.89% | 37.72% | 30.59% | Upgrade
|
| Buyback Yield / Dilution | -0.01% | 0.01% | 0.00% | 0.01% | -12.85% | -3.99% | Upgrade
|
| Total Shareholder Return | 3.85% | 3.41% | 3.28% | 3.89% | -9.15% | -0.99% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.